Clinical Trial Update: Adebrelimab Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) [NA]

View source ↗

Summary

A clinical trial evaluating adebrelimab in combination with chemoradiotherapy for locally advanced unresectable esophageal squamous cell carcinoma has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Esophageal Squamous Cell Carcinoma | NA | Status: WITHDRAWN